Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

ClinicalTrials.gov ID: NCT00244244

Public ClinicalTrials.gov record NCT00244244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS)

Study identification

NCT ID
NCT00244244
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CytRx
Industry
Enrollment
80 participants

Conditions and interventions

Interventions

  • arimoclomol Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2005
Primary completion
Dec 31, 2006
Completion
Dec 31, 2006
Last update posted
Feb 8, 2012

2005 – 2007

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
University of California, Irvine Medical Center Irvine California 92868
University of Miami School of Medicine Miami Florida 33136
University of Kansas Medical Center Kansas City Kansas 66160
Massachusetts General Hospital Boston Massachusetts 02129
Hennepin Faculty Associates/Berman Center Minneapolis Minnesota 55404
SUNY Upstate Medical University Syracuse New York 13210
Duke University Durham North Carolina 27705
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Drexel University College of Medicine Philadelphia Pennsylvania 19107
University of Texas Health Science Center at San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00244244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00244244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →